tiprankstipranks
CANNOVUM AG (DE:27N0)
XETRA:27N0
Germany Market
Holding DE:27N0?
Track your performance easily

CANNOVUM AG (27N0) Stock Price & Analysis

1 Followers

27N0 Stock Chart & Stats


Financials

Annual

27N0 FAQ

What was CANNOVUM AG’s price range in the past 12 months?
CANNOVUM AG lowest stock price was €0.20 and its highest was €7.90 in the past 12 months.
    What is CANNOVUM AG’s market cap?
    Currently, no data Available
    When is CANNOVUM AG’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were CANNOVUM AG’s earnings last quarter?
    Currently, no data Available
    Is CANNOVUM AG overvalued?
    According to Wall Street analysts CANNOVUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does CANNOVUM AG pay dividends?
      CANNOVUM AG does not currently pay dividends.
      What is CANNOVUM AG’s EPS estimate?
      CANNOVUM AG’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does CANNOVUM AG have?
      CANNOVUM AG has 2,311,140 shares outstanding.
        What happened to CANNOVUM AG’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of CANNOVUM AG?
        Currently, no hedge funds are holding shares in DE:27N0
        ---

        Company Description

        CANNOVUM AG

        CANNOVUM AG is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. It focuses on the import of medical cannabis, medical-scientific education, and distribution for facilitated access to cannabis-based therapies.
        ---
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis